Back
Evolent Health Quote, Financials, Valuation and Earnings
![](/images/offers/ims/large/offer2.jpg)
Free presentation on how to trade options for overnight gains
Get the free overnight options training here.
Buy
62
EVH
Evolent Health
Last Price:
23.68
Seasonality Move:
-3.35%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer5.jpg)
Groundbreaking AI Developed In Small Georgia Town Destroys Wall Street
See the remarkable discovery.Evolent Health Price Quote
$23.68
+1.49 (+6.71%)
(Updated: July 26, 2024 at 6:50 PM ET)
Evolent Health Key Stats
Buy
62
Evolent Health (EVH)
is a Buy
Day range:
$21.14 - $23.24
52-week range:
$17.98 - $35.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.15
P/B ratio:
2.43%
Volume:
3.7M
Avg. volume:
2.2M
1-year change:
-25.54%
Market cap:
$2.5B
Revenue:
$2B
EPS:
$-1.25
How Much Does Evolent Health Make?
-
How Much Are Evolent Health's Sales Annually?
EVH Revenues are $2B -
How Much Profit Does Evolent Health's Make A Year?
EVH net income is -$113M
Is Evolent Health Growing As A Company?
-
What Is Evolent Health's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.5% -
What Is Evolent Health's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Evolent Health Stock Price Performance
-
Did Evolent Health Stock Go Up Last Month?
Evolent Health share price went up by 6.43% last month -
Did EVH's Share Price Rise Over The Last Year?
EVH share price fell by -25.54% over the past 1 year
What Is Evolent Health 52-Week High & Low?
-
What Is Evolent Health’s 52-Week High Share Price?
Evolent Health has traded as high as $35.00 over the past 52 weeks -
What Is Evolent Health’s 52-Week Low Share Price?
Evolent Health has traded as low as $17.98 over the past 52 weeks
Evolent Health Price To Free Cash Flow
-
Is Evolent Health Stock Overvalued?
Evolent Health is trading at a price to free cash flow ratio of 19.20 -
Is Evolent Health Stock Undervalued?
Evolent Health EV to Free Cash Flow ratio is 22.83 -
What Is Evolent Health’s Price Earnings Growth Ratio?
EVH PEG ratio is -0.08 -
Is Evolent Health Trading At A Premium To Earnings?
Evolent Health EV to EBIT ratio is 0.00
Is It Risky To Buy Evolent Health?
-
How Much Debt Does Evolent Health Have?
Total long term debt quarterly is $597.9M -
How Much Cash Does Evolent Health Have?
Cash and short term investments quarterly total is $165.1M -
What Is Evolent Health’s Book Value Per Share?
Book value per share is 9.14
Is Evolent Health Cash Flow Positive?
-
What Is EVH Cash Flow From Operations?
Cash flow from operations (TTM) is $155.5M -
What Is Evolent Health’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$83.5M -
What Is Evolent Health’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$30.3M
Evolent Health Return On Invested Capital
-
Is Management Doing A Good Job?
EVH return on invested capital is -6.37% -
What Is Evolent Health Return On Assets?
ROA measures how assets are converting to revenues and is -4.17% -
What Is EVH Return On Equity?
ROE is a measure of profitability and is -9.86%
Evolent Health Earnings Date & Stock Price
-
What Is Evolent Health's Stock Price Today?
A single share of EVH can be purchased today for 22.19 -
What Is Evolent Health’s Stock Symbol?
Evolent Health trades on the nyse under the ticker symbol: EVH -
When Is Evolent Health’s Next Earnings Date?
The next quarterly earnings date for Evolent Health is scheduled on August 8, 2024 -
When Is EVH's next ex-dividend date?
Evolent Health's next ex-dividend date is July 26, 2024 -
How To Buy Evolent Health Stock?
You can buy Evolent Health shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Evolent Health Competitors
-
Who Are Evolent Health's Competitors?
Below is a list of companies who compete with Evolent Health or are related in some way:
Evolent Health Dividend Yield
Data Unavailable
Evolent Health Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 15.25% |
Revenue: | 49.56% | 6.8% |
Analyst Recommendations
Buy Recommendations: | 9 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 41.36 |
Upside from Last Price: | 86.38% |